January 2013 Issue of MMM
January 2013 issue MM&M
Too often "innovation" translates to "finding the best way to cut budgets"
Sanofi proves its pluck: Not only did Sanofi face down the patent cliff in 2012, Matthew Arnold reports, it made bold moves in the digital ...
Data-driven talent magnet: Creating an environment that optimizes talent development pays off for the Toronto agency. Tanya Lewis reports
Vim, vigor and sales drive: Uncovering the market for what has been a taboo topic is a tricky goal, but this brand did it. Larry ...
An ultrarare success: Marc Iskowitz on how an innovative approach helped this brand carve out a spot for itself in the biotech big leagues
Patient portal picks up pace: Deborah Weinstein on how moving back to basics, and responding to its audience, has helped this web portal grow
With the impending US approval of their oral blood thinner, this could be a big year for Bristol-Myers Squibb. But the other two warfarin replacements ...
As it became evident that a large HCV+ cohort would likely need medical intervention, pharma responded
The real story is not the risk of statin drugs but the media's presentation of it.
Pushing back against complaints that the drug approvals process moves too slowly in the US, FDA issued a report saying it kept pace with its ...
Breakfast may be called the most important meal of the day, but MedScape's 2012 Ethics Survey results show that lunch also weighs on doctors' minds.
Companies can improve their performance by blending hard numbers, like outcomes and cost savings, with softer messaging that centers on payer and patient relationships, a ...
News on GolinHarris, McKesson and Shire
Med Ed Report
The number of healthcare providers who use electronic health records has risen thanks to meaningful-use incentives and other factors.
The State Medical Board of Ohio pulled out of a pilot project designed to evaluate new education requirements, dealing a setback to the movement.
Pfizer paid about $55 million to resolve allegations that Wyeth, which it bought in 2009, used CME to promote Protonix for off-label use, the Justice ...
News on Omnipress, Doctors.net.uk, WorldEvents and OMB
Data from three publication groups indicate that it's still too soon for publishers to ditch print for digital-only publications,
Monthly Prescribing Reference has unveiled a redesign—its first since 2009.
News on the Wall Street Journal, Nature and Elsevier
Specialty pharma budgets can be smaller than in primary care, yet the conversations with specialists and payers are often more complex. How do you maximize ...
WebMD is laying off 14% of its workforce in hopes of saving $45 million to offset revenue losses from an ad slump that plagued the ...
Remedy Health is launching a service letting doctors, pharmacies and other healthcare providers send topical health content to their patients.
News on Durex, MobiHealth News and Cochrane Collaboration
OraSure, the maker of the recently approved home HIV test, has hired an experienced consumer marketer from Pfizer to head up the launch for the ...
Xarelto's DTC campaign is humanizing the brand and making it memorable—at least for its target group of men 65 and over who have AFib and ...
A new campaign from J&J's DePuy Orthopedics to raise awareness of joint replacement, features Baby Boomers' letters to their younger selves.
PatientsLikeMe, the online patient network and research platform, appointed Daphne Psacharopoulos to the new position of VP, client services and strategic initiatives
Law firm Morrison & Foerster launched a that indexes average up-front payments in agreements between biotech companies and companies that pay for commercialization rights.
AccentHealth is acquiring Havas Impact, the holding company's waiting room "WallBoards" arm, in a move that will double the New York firm's footprint.
News on Sudler & Hennessey, Topin & Associates, inVentiv Health and W2O Group
The image of pharma as corrupt is not a problem of perception. It's one of fact.
A new report says that FDA still has significant workforce and management challenges in the scientific and medical arenas that need to be addressed
An FDA Warning Letter says that oBand Centers is making misleading claims in its promotional materials for the Lap-Band
The environment is ripe for digital health; it's the way consumers are consuming their information
The ACA will have a lasting impact on how providers treat patients and how doctors order care
Taking a look at some creative approaches agencies have taken to help make a product jump off the page
Mark Myslinski, Chief Commercial Officer, Saladax Biomedical
At Work With
Jaime Butler-Binley, Creative Team, FingerPaint Marketing
Industry, agency and media hires and promotions
The question is not whether you should do it, but how to do it successfully
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.